<DOC>
	<DOCNO>NCT00003186</DOCNO>
	<brief_summary>RATIONALE : Diagnostic procedure , lymphography , may improve identification patient metastatic colorectal cancer . PURPOSE : Clinical trial study effectiveness lymphography determine presence absence metastatic colorectal cancer patient .</brief_summary>
	<brief_title>Diagnostic Procedure Identifying Patients With Metastatic Colorectal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Confirm injection isosulfan blue mucosa serosa immediately adjacent colorectal cancer result lymphatic transport agent initially specific regional lymph node readily identify visual inspection , dissect , histologically evaluate presence absence metastatic disease . OUTLINE : All patient receive injection isosulfan blue peritumor serosa upon intraoperative identification primary tumor , prior mesenteric mobilization . If colonoscopy otherwise indicate , injection may deliver peritumor mucosa via colonoscopy case . The mesentery adjacent injection inspect lymphatic pattern node demonstrate isosulfan blue diagram photograph . The sentinel node ( ) surgically dissect evaluate . If need , second injection isosulfan blue may give . Prior mobilization liver resection metastasis , isosulfan blue inject subcapsularly around metastatic lesion . PROJECTED ACCRUAL : There 10 patient accrue study .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients must undergo surgical resection colorectal primary adenocarcinoma Metastatic colorectal cancer liver ( hepatic metastasis ) allow PATIENT CHARACTERISTICS : Age : 18 75 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No know suspect allergy isosulfan blue Not pregnant PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>stage I colon cancer</keyword>
	<keyword>stage II colon cancer</keyword>
	<keyword>stage III colon cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage I rectal cancer</keyword>
	<keyword>stage II rectal cancer</keyword>
	<keyword>stage III rectal cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>adenocarcinoma colon</keyword>
	<keyword>liver metastasis</keyword>
</DOC>